Recent News

• 04.24.2025 - BioAtla Announces Poster Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting
• 04.24.2025 - BioAtla Announces Poster Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting
• 04.23.2025 - BioAtla Announces Upcoming Poster Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
• 04.23.2025 - BioAtla Announces Upcoming Poster Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
• 03.27.2025 - BioAtla Fourth Quarter 2024 Financial Results and Business Highlights Conference Call
• 03.27.2025 - BioAtla Fourth Quarter 2024 Financial Results and Business Highlights Conference Call
• 03.27.2025 - BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress
• 03.27.2025 - BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress
• 03.20.2025 - BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings
• 03.20.2025 - BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings

Recent Filings

• 03.28.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.28.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.27.2025 - EX-99.1 EX-99.1
• 03.27.2025 - 8-K Current report
• 03.18.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 03.14.2025 - 8-K Current report
• 03.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.13.2025 - 4 Statement of changes in beneficial ownership of securities